HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Brust Selected Research

2-fluoro-3-(2-azetidinylmethoxy)pyridine

3/2008In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine.
3/2008Acetylcholine receptors in dementia and mild cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Brust Research Topics

Disease

20Neoplasms (Cancer)
03/2022 - 10/2012
9Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 03/2006
9Alzheimer Disease (Alzheimer's Disease)
01/2021 - 03/2008
6Traumatic Brain Injuries (Traumatic Brain Injury)
06/2016 - 09/2007
5Brain Neoplasms (Brain Tumor)
01/2022 - 05/2007
5Parkinson Disease (Parkinson's Disease)
01/2021 - 08/2009
4Obesity
04/2022 - 12/2014
4Pathologic Processes
05/2021 - 10/2012
4Hypoxia (Hypoxemia)
05/2021 - 04/2002
3Body Weight (Weight, Body)
03/2021 - 03/2005
3Dementia (Dementias)
01/2018 - 03/2008
3Brain Injuries (Brain Injury)
06/2016 - 12/2008
2Neuroinflammatory Diseases
01/2021 - 01/2016
2Glioblastoma (Glioblastoma Multiforme)
05/2020 - 03/2018
2Cognitive Dysfunction
01/2018 - 03/2008
2Substance-Related Disorders (Drug Abuse)
06/2017 - 03/2016
2Mental Disorders (Mental Disorder)
01/2017 - 07/2007
2Weight Loss (Weight Reduction)
01/2017 - 01/2016
2Depressive Disorder (Melancholia)
09/2015 - 08/2009
2Brain Diseases (Brain Disorder)
10/2014 - 05/2012
1Ischemia
01/2022
1Hypothermia
12/2021
1Hypothyroidism
12/2021
1Neoplastic Processes
05/2021
1Inflammation (Inflammations)
05/2021
1Animal Disease Models
03/2021
1Edema (Dropsy)
03/2021
1Fibrosis (Cirrhosis)
03/2021
1Proteinuria
03/2021
1Channelopathies
03/2021
1Huntington Disease (Huntington's Disease)
01/2021
1Acidosis
04/2020
1Sarcopenia
01/2020
1Muscular Atrophy (Muscle Atrophy)
01/2020
1Melanoma (Melanoma, Malignant)
03/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2018
1Carcinoma (Carcinomatosis)
03/2018
1Disease Progression
01/2018
1Morbid Obesity
01/2017
1Hyperthyroidism
12/2016
1Contusions
06/2016
1Schizophrenia (Dementia Praecox)
03/2016

Drug/Important Bio-Agent (IBA)

11Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 03/2006
6Cholinergic Agents (Cholinergics)IBA
01/2018 - 09/2007
5Pharmaceutical PreparationsIBA
12/2019 - 08/2011
4Adenosine A2B ReceptorIBA
04/2022 - 01/2020
4LigandsIBA
05/2021 - 03/2008
4fluoronorchloroepibatidineIBA
01/2021 - 04/2013
3Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022 - 01/2014
3Proteins (Proteins, Gene)FDA Link
05/2021 - 06/2016
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
02/2021 - 04/2020
31'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA
01/2021 - 03/2018
3Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2015
2Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2022 - 01/2022
2Adenosine (Adenocard)FDA LinkGeneric
05/2021 - 01/2020
2RotenoneIBA
01/2021 - 04/2020
2Cyclic NucleotidesIBA
01/2017 - 04/2016
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2017 - 01/2016
2sigma-2 receptorIBA
02/2016 - 10/2012
2Haloperidol (Haldol)FDA LinkGeneric
07/2015 - 08/2014
2Biological ProductsIBA
07/2015 - 10/2012
22-fluoro-3-(2-azetidinylmethoxy)pyridineIBA
03/2008 - 03/2008
2Levodopa (L Dopa)FDA LinkGeneric
05/2007 - 04/2002
1Histone Deacetylases (Histone Deacetylase)IBA
03/2022
1Histone Deacetylase InhibitorsIBA
03/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1SurvivinIBA
01/2022
1Thyroid HormonesIBA
12/2021
1LeptinIBA
12/2021
1CholesterolIBA
05/2021
1Radioisotopes (Radionuclides)IBA
05/2021
1Fluorine-18IBA
05/2021
1GTP-Binding Proteins (G-Protein)IBA
05/2021
1psb-603IBA
05/2021
1XanthineIBA
05/2021
1TRPC6 Cation ChannelIBA
03/2021
1SH045IBA
03/2021
1Transient Receptor Potential ChannelsIBA
03/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Selegiline (E250)FDA LinkGeneric
01/2021
1pridopidineIBA
01/2021
1Monoamine Oxidase (MAO)IBA
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1fallyprideIBA
01/2021
1Investigational DrugsIBA
01/2021
1Sigma-1 ReceptorIBA
05/2020
1Monocarboxylic Acid TransportersIBA
04/2020
1Lactic Acid (Lactate)FDA LinkGeneric
04/2020
1Therapeutic UsesIBA
12/2019
1Antineoplastic Agents (Antineoplastics)IBA
03/2018
1Cholinesterases (Cholinesterase)IBA
01/2018
1NicotineFDA Link
06/2017
1CannabinoidsIBA
05/2017
1Adrenergic Agents (Adrenergic Drugs)IBA
12/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2016
1Amyloid beta-PeptidesIBA
08/2016
1Messenger RNA (mRNA)IBA
06/2016

Therapy/Procedure

12Therapeutics
03/2022 - 12/2014
2Bariatric Surgery
01/2017 - 01/2016
1Drug Therapy (Chemotherapy)
01/2019